{"entity":{"type":"insider","cik":"0001332669","url":"/insider/0001332669","json_url":"/insider/0001332669.json","name":"Maslan Andrew Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":10,"first":"2006-11-07","last":"2012-07-03","span_basis":"filed_date"},"name_variants":[{"name":"Maslan Andrew Scott","source":"filing","n_filings":10,"first_seen":"2006-11-07","last_seen":"2012-07-03"}],"transactions":[{"id":2543883,"accession":"0001144204-12-037941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-037941","line_url":"/filing/0001144204-12-037941#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"CMXI","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001332669","owner_name":"Maslan Andrew Scott","owner_display_name":"Maslan Andrew Scott","owner_url":"/insider/0001332669","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","total_whole":"5,400","shares_owned_after":102780.0,"shares_owned_after_display":"102,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-03","filed_date":"2012-07-03","scope":"insider"},{"id":9077507,"accession":"0001144204-11-019001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-019001","line_url":"/filing/0001144204-11-019001#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"CMXI","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001332669","owner_name":"Maslan Andrew Scott","owner_display_name":"Maslan Andrew Scott","owner_url":"/insider/0001332669","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.36,"price_display":"0.36","price_state":"stated","total_value":3600.0,"total_display":"3,600.00","total_whole":"3,600","shares_owned_after":67940.0,"shares_owned_after_display":"67,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-31","filed_date":"2011-03-31","scope":"insider"},{"id":5620920,"accession":"0001144204-09-043693","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-09-043693","line_url":"/filing/0001144204-09-043693#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001332669","owner_name":"Maslan Andrew Scott","owner_display_name":"Maslan Andrew Scott","owner_url":"/insider/0001332669","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8800.0,"shares_display":"8,800","price_per_share":0.57,"price_display":"0.57","price_state":"stated","total_value":5016.0,"total_display":"5,016.00","total_whole":"5,016","shares_owned_after":56500.0,"shares_owned_after_display":"56,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-14","filed_date":"2009-08-14","scope":"insider"},{"id":6016890,"accession":"0001144204-09-029368","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-09-029368","line_url":"/filing/0001144204-09-029368#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001332669","owner_name":"Maslan Andrew Scott","owner_display_name":"Maslan Andrew Scott","owner_url":"/insider/0001332669","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.52,"price_display":"0.52","price_state":"stated","total_value":1300.0,"total_display":"1,300.00","total_whole":"1,300","shares_owned_after":47700.0,"shares_owned_after_display":"47,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-22","filed_date":"2009-05-26","scope":"insider"},{"id":6050892,"accession":"0001144204-09-000452","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-09-000452","line_url":"/filing/0001144204-09-000452","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001332669","owner_name":"Maslan Andrew Scott","owner_display_name":"Maslan Andrew Scott","owner_url":"/insider/0001332669","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5200.0,"shares_display":"5,200","price_per_share":0.26653846153846156,"price_display":"0.27","price_state":"stated","total_value":1386.0,"total_display":"1,386.00","total_whole":"1,386","shares_owned_after":45200.0,"shares_owned_after_display":"45,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-06","scope":"insider","n_lines":2},{"id":3405723,"accession":"0001144204-08-069271","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-08-069271","line_url":"/filing/0001144204-08-069271#line-2","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001332669","owner_name":"Maslan Andrew Scott","owner_display_name":"Maslan Andrew Scott","owner_url":"/insider/0001332669","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4800.0,"shares_display":"4,800","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":1824.0,"total_display":"1,824.00","total_whole":"1,824","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-15","filed_date":"2008-12-15","scope":"insider"},{"id":3405722,"accession":"0001144204-08-069271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-08-069271","line_url":"/filing/0001144204-08-069271#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001332669","owner_name":"Maslan Andrew Scott","owner_display_name":"Maslan Andrew Scott","owner_url":"/insider/0001332669","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":68.0,"total_display":"68.00","total_whole":"68","shares_owned_after":35200.0,"shares_owned_after_display":"35,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-12","filed_date":"2008-12-15","scope":"insider"},{"id":3968693,"accession":"0001144204-08-069093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-08-069093","line_url":"/filing/0001144204-08-069093#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001332669","owner_name":"Maslan Andrew Scott","owner_display_name":"Maslan Andrew Scott","owner_url":"/insider/0001332669","role":"Officer (Officer)","role_mark":"O","role_mark_label":"Officer (Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":2040.0,"total_display":"2,040.00","total_whole":"2,040","shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-10","filed_date":"2008-12-12","scope":"insider"},{"id":3682885,"accession":"0001144204-08-051824","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-08-051824","line_url":"/filing/0001144204-08-051824#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001332669","owner_name":"Maslan Andrew Scott","owner_display_name":"Maslan Andrew Scott","owner_url":"/insider/0001332669","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":29000.0,"shares_owned_after_display":"29,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-05","filed_date":"2008-09-09","scope":"insider"},{"id":3650228,"accession":"0001144204-08-020403","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-08-020403","line_url":"/filing/0001144204-08-020403","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001332669","owner_name":"Maslan Andrew Scott","owner_display_name":"Maslan Andrew Scott","owner_url":"/insider/0001332669","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.7488,"price_display":"0.75","price_state":"stated","total_value":3744.0,"total_display":"3,744.00","total_whole":"3,744","shares_owned_after":8600.0,"shares_owned_after_display":"8,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-03","filed_date":"2008-04-03","scope":"insider","n_lines":2},{"id":3373780,"accession":"0001188080-06-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001188080-06-000013","line_url":"/filing/0001188080-06-000013#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"GTF","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001332669","owner_name":"Maslan Andrew Scott","owner_display_name":"Maslan Andrew Scott","owner_url":"/insider/0001332669","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":4560.0,"total_display":"4,560.00","total_whole":"4,560","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-07","filed_date":"2006-11-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001091596","name":"CYTOMEDIX INC","url":"/issuer/0001091596","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":10,"first_seen":"2006-11-07","last_seen":"2012-07-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001332669","retrieved_at":"2026-08-26T05:01:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}